Abstract
In August 2008, romiplostim (Nplate; Amgen), a thrombopoietin receptor agonist, was approved by the US FDA for the treatment of thrombocytopaenia in patients with chronic immune thrombocytopaenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Cines, D. B. & Blanchette, V. S. Immune thrombocytopenic purpura. N. Engl. J. Med. 346, 995–1008 (2002).
Ballem, P. J. et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J. Clin. Invest. 80, 33–40 (1987).
Kaushansky, K. Historical review: megakaryopoiesis and thrombopoiesis. Blood 111, 981–986 (2008).
Nomura, S. et al. Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood 100, 728–730 (2002).
Li, J. et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98, 3241–3248 (2001).
Broudy, V. C. & Lin, N. L. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 25, 52–60 (2004).
Food and Drug Administration. FDA labelling information. FDA web site [online], (2008).
Wang, B. et al. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin. Pharmacol. Ther. 76, 628–638 (2004).
Bussel, J. B. et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N. Engl. J. Med. 355, 1672–1681 (2006).
Kuter, D. J. et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 371, 395–403 (2008).
Cooper N. et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br. J. Haematol. 125, 232–239 (2004).
Godeau, B. et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood 112, 999–1004 (2008).
Cohen, Y. C. et al. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch. Int. Med. 160, 1630–1638 (2000).
Bussel, J. B. et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N. Engl. J. Med. 357, 2237–2247 (2007).
McHutchison, J. G. et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N. Engl. J. Med. 357, 2227–2236 (2007).
Holley, B. et al. Oppenheimer Equity Research Report (Oppenheimer, 25 Aug 2008).
IMS MIDAS (2007).
To, A. Amgen (Natixis Bleichroeder, 06 March 2008).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Dr Cines is not employed by, holds financial interest in, nor receives research funding from any corporation that would represent a conflict of interest. Dr Cines has served on medical advisory boards for Amgen, GlaxoSmithKline, Biovitrum, on the Data Safety Monitoring Board for Rigel Pharmaceuticals and has acted as an ad-hoc consultant for Baxter, Bayer, Biogen, Chroma Therapeutics, Ligand and ZLB Behring.
Rights and permissions
About this article
Cite this article
Cines, D., Yasothan, U. & Kirkpatrick, P. Romiplostim. Nat Rev Drug Discov 7, 887–888 (2008). https://doi.org/10.1038/nrd2741
Issue date:
DOI: https://doi.org/10.1038/nrd2741
This article is cited by
-
Genetically Fused DARPins: A Novel Approach for Designing Extended-Release Thrombopoietin Mimetic Peptides
International Journal of Peptide Research and Therapeutics (2023)
-
The Types and Applications of Peptibodies
International Journal of Peptide Research and Therapeutics (2023)
-
Expression, purification and biological activity assessment of romiplostim biosimilar peptibody
DARU Journal of Pharmaceutical Sciences (2016)
-
Exogenous endothelial cells as accelerators of hematopoietic reconstitution
Journal of Translational Medicine (2012)
